| Utility: Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC and other cancers Filling date: 9 Sep 2025 Issue date: 26 Jan 2021 | 29 Jun 2020 | 26 Jan 2021 |
| Utility: Method of treating with a peptide Filling date: 9 Sep 2025 Issue date: 26 Jan 2021 | 29 Jun 2020 | 26 Jan 2021 |
| Utility: Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers Filling date: 9 Sep 2025 Issue date: 26 Jan 2021 | 26 Jun 2020 | 26 Jan 2021 |
| Utility: Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers Filling date: 9 Sep 2025 Issue date: 26 Jan 2021 | 26 Jun 2020 | 26 Jan 2021 |
| Utility: Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers Filling date: 9 Sep 2025 Issue date: 26 Jan 2021 | 26 Jun 2020 | 26 Jan 2021 |
| Utility: Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Filling date: 9 Sep 2025 Issue date: 26 Jan 2021 | 26 Jun 2020 | 26 Jan 2021 |
| Utility: Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Filling date: 9 Sep 2025 Issue date: 26 Jan 2021 | 26 Jun 2020 | 26 Jan 2021 |
| Utility: Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers Filling date: 9 Sep 2025 Issue date: 26 Jan 2021 | 24 Jun 2020 | 26 Jan 2021 |
| Utility: Cell epitopes and combination of cell epitopes for use in the immunotherapy of myeloma and other cancers Filling date: 9 Sep 2025 Issue date: 26 Jan 2021 | 16 Jun 2020 | 26 Jan 2021 |
| Utility: Immunotherapy against several tumors including gastrointestinal and gastric cancer Filling date: 9 Sep 2025 Issue date: 26 Jan 2021 | 5 Jun 2020 | 26 Jan 2021 |
| Utility: Method of treating with a peptide Filling date: 9 Sep 2025 Issue date: 26 Jan 2021 | 29 May 2020 | 26 Jan 2021 |
| Utility: Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers Filling date: 9 Sep 2025 Issue date: 26 Jan 2021 | 17 Apr 2020 | 26 Jan 2021 |
| Utility: Peptides and combination of peptides for use in immunotherapy against leukemias and other cancers Filling date: 9 Sep 2025 Issue date: 26 Jan 2021 | 10 Apr 2018 | 26 Jan 2021 |
| Utility: Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Filling date: 9 Sep 2025 Issue date: 19 Jan 2021 | 5 Apr 2019 | 19 Jan 2021 |
| Utility: Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers Filling date: 9 Sep 2025 Issue date: 12 Jan 2021 | 18 Jun 2020 | 12 Jan 2021 |
| Utility: Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Filling date: 9 Sep 2025 Issue date: 12 Jan 2021 | 12 Jun 2020 | 12 Jan 2021 |
| Utility: Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Filling date: 9 Sep 2025 Issue date: 12 Jan 2021 | 12 Jun 2020 | 12 Jan 2021 |
| Utility: Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Filling date: 9 Sep 2025 Issue date: 12 Jan 2021 | 12 Jun 2020 | 12 Jan 2021 |
| Utility: Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Filling date: 9 Sep 2025 Issue date: 12 Jan 2021 | 27 Mar 2020 | 12 Jan 2021 |
| Utility: Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Filling date: 9 Sep 2025 Issue date: 12 Jan 2021 | 10 Mar 2020 | 12 Jan 2021 |
| Utility: Transfected T-cells and T-cell receptors for use in immunotherapy against cancers Filling date: 9 Sep 2025 Issue date: 12 Jan 2021 | 9 Mar 2020 | 12 Jan 2021 |
| Utility: Engineered T cell receptors and immune therapy using the same Filling date: 9 Sep 2025 Issue date: 12 Jan 2021 | 7 Jan 2020 | 12 Jan 2021 |
| Utility: Cell epitopes and combination of cell epitopes for use in the immunotherapy of myeloma and other cancers Filling date: 9 Sep 2025 Issue date: 12 Jan 2021 | 29 May 2019 | 12 Jan 2021 |
| Utility: Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers Filling date: 9 Sep 2025 Issue date: 5 Jan 2021 | 18 Jun 2020 | 5 Jan 2021 |
| Utility: Immunotherapy against several tumors of the blood, in particular chronic lymphoid leukemia (CLL) Filling date: 9 Sep 2025 Issue date: 29 Dec 2020 | 24 Jun 2020 | 29 Dec 2020 |
| Utility: Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Filling date: 9 Sep 2025 Issue date: 29 Dec 2020 | 22 May 2020 | 29 Dec 2020 |
| Utility: Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Filling date: 9 Sep 2025 Issue date: 29 Dec 2020 | 1 May 2020 | 29 Dec 2020 |
| Utility: T cell receptors and immune therapy using the same Filling date: 9 Sep 2025 Issue date: 29 Dec 2020 | 7 Dec 2017 | 29 Dec 2020 |
| Utility: Immunotherapy with A*01 restricted peptides and combination of peptides against cancers and related methods Filling date: 9 Sep 2025 Issue date: 22 Dec 2020 | 30 Jun 2020 | 22 Dec 2020 |
| Utility: A*03 restricted peptides for use in immunotherapy against cancers and related methods Filling date: 9 Sep 2025 Issue date: 22 Dec 2020 | 30 Jun 2020 | 22 Dec 2020 |
| Utility: Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers Filling date: 9 Sep 2025 Issue date: 22 Dec 2020 | 18 Jun 2020 | 22 Dec 2020 |
| Utility: Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Filling date: 9 Sep 2025 Issue date: 22 Dec 2020 | 12 Jun 2020 | 22 Dec 2020 |
| Utility: Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Filling date: 9 Sep 2025 Issue date: 22 Dec 2020 | 12 Jun 2020 | 22 Dec 2020 |
| Utility: Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Filling date: 9 Sep 2025 Issue date: 22 Dec 2020 | 22 May 2020 | 22 Dec 2020 |
| Utility: Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Filling date: 9 Sep 2025 Issue date: 22 Dec 2020 | 22 May 2020 | 22 Dec 2020 |
| Utility: Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Filling date: 9 Sep 2025 Issue date: 22 Dec 2020 | 22 May 2020 | 22 Dec 2020 |
| Utility: Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Filling date: 9 Sep 2025 Issue date: 22 Dec 2020 | 11 May 2020 | 22 Dec 2020 |
| Utility: Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Filling date: 9 Sep 2025 Issue date: 22 Dec 2020 | 11 May 2020 | 22 Dec 2020 |
| Utility: Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers Filling date: 9 Sep 2025 Issue date: 24 Nov 2020 | 24 Jun 2020 | 24 Nov 2020 |
| Utility: Peptides and combination of peptides as targets or active ingredients for use in immunotherapy against AML and other cancers Filling date: 9 Sep 2025 Issue date: 17 Nov 2020 | 29 Jun 2020 | 17 Nov 2020 |
| Utility: Peptides and combination of peptides as targets or active ingredients for use in immunotherapy against AML and other cancers Filling date: 9 Sep 2025 Issue date: 17 Nov 2020 | 24 Jun 2020 | 17 Nov 2020 |
| Utility: Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers Filling date: 9 Sep 2025 Issue date: 17 Nov 2020 | 1 May 2020 | 17 Nov 2020 |
| Utility: Peptides and combination of peptides and scaffolds for use in immunotherapy against renal cell carcinoma (RCC) and other cancers Filling date: 9 Sep 2025 Issue date: 17 Nov 2020 | 16 Dec 2019 | 17 Nov 2020 |
| Utility: Anti-WT1/HLA-specific antibodies Filling date: 9 Sep 2025 Issue date: 17 Nov 2020 | 7 Oct 2016 | 17 Nov 2020 |
| Utility: Peptides and combination of peptides for use in immunotherapy against esophageal cancer and other cancers Filling date: 9 Sep 2025 Issue date: 10 Nov 2020 | 29 May 2020 | 10 Nov 2020 |
| Utility: A*03 restricted peptides for use in immunotherapy against cancers and related methods Filling date: 9 Sep 2025 Issue date: 10 Nov 2020 | 29 May 2020 | 10 Nov 2020 |
| Utility: Peptides and combination of peptides for use in immunotherapy and methods for generating scaffolds for the use against pancreatic cancer and other cancers Filling date: 9 Sep 2025 Issue date: 3 Nov 2020 | 21 May 2018 | 3 Nov 2020 |
| Utility: Peptides and combination of peptides for use in immunotherapy against NHL and other cancers Filling date: 9 Sep 2025 Issue date: 27 Oct 2020 | 3 Jun 2020 | 27 Oct 2020 |
| Utility: Immunotherapy against several tumors of the blood, such as acute myeloid leukemia (aml) Filling date: 9 Sep 2025 Issue date: 27 Oct 2020 | 20 Apr 2020 | 27 Oct 2020 |
| Utility: Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Filling date: 9 Sep 2025 Issue date: 27 Oct 2020 | 13 Feb 2020 | 27 Oct 2020 |
